Sign inJoin waitlistJoin the waitlist

Vinod Rustgi

Clinical Director of Hepatology · Rutgers Health

Credentials: · · · · · · · · · ·

History

Hepatology · Rutgers Health
Present
Rutgers Health
Present
Rutgers Health
Present

Gastroenterology
Stanford Health Care
1982–1985
National Institute of Health
Internal Medicine
MedStar Health Georgetown University
1980–1982
Baylor College of Medicine
1979–1980
Johns Hopkins School of Medicine
1975–1979
Yale University
1971–1975

Research

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
The Lancet · 2001 · 5,067 citations
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group
New England Journal of Medicine · 1998 · 2,880 citations
Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group
New England Journal of Medicine · 1998 · 1,119 citations

Abhishek Bhurwal
16 papers · 16 as a fellow
KG
Kapil Gupta
15 papers · 14 as a fellow
Ankoor Patel
11 papers · 11 as a resident
Eric Lawitz
11 papers
JH
Jay Hoofnagle
10 papers
Stuart Gordon
10 papers
Adrian Di Bisceglie
9 papers
Christopher Tait
9 papers
Mitchell Shiffman
9 papers
DR
Debashis Reja
8 papers · 8 as a fellow
JM
John McHutchison
8 papers
LJ
Lynt Johnson
8 papers

Clinical trials

Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients
Principal investigator · Completed · Phase 2
Romark Laboratories L.C.
2008–2010
HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection
Principal investigator · Terminated · Phase 2
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
2005